| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/02/2023 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 50k | $36.80 | $1.8M | | 02/02/2023 |
| 02/02/2023 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 50k | $36.80 | $1.8M | | 02/02/2023 |
| 02/02/2023 | Viridian Therapeutics, Inc.\DE | MGEN | Exercise | Stock Option (Right to Buy) | 50k | $0.15 | $7.5k | | 02/02/2023 |
| 06/09/2022 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 8.3k | $0.00 | $0 | | 06/09/2022 |
| 06/09/2022 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 8.3k | $2.99 | $24.9k | | 06/09/2022 |
| 06/01/2022 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 30k | $12.20 | $366k | | 06/01/2022 |
| 05/02/2022 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 30k | $13.04 | $391.2k | | 05/02/2022 |
| 04/04/2022 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 3.6k | $18.93 | $68.1k | | 04/01/2022 |
| 04/01/2022 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 26.4k | $18.92 | $499.5k | | 04/01/2022 |
| 03/02/2022 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 11.1k | $17.36 | $192.8k | | 03/01/2022 |
| 03/01/2022 | Viridian Therapeutics, Inc.\DE | MGEN | Sale | Common Stock | 18.9k | $17.82 | $336.7k | | 03/01/2022 |
| 12/08/2021 | Viridian Therapeutics, Inc.\DE | MGEN | Conversion | Series A Non-Voting Convertible Preferred Stock | 9.4k | $0.00 | $0 | | 12/08/2021 |
| 12/08/2021 | Viridian Therapeutics, Inc.\DE | MGEN | Conversion | Common Stock | 627.6k | $0.00 | $0 | | 12/08/2021 |
| 09/20/2021 | Astria Therapeutics, Inc. | ATXS | Other (acquisition) | Common Stock | 263.3k | $0.00 | $0 | | 09/20/2021 |
| 09/20/2021 | Astria Therapeutics, Inc. | ATXS | Other (disposition) | Common Stock | 263.3k | $0.00 | $0 | By Lazarus Life Sciences I, LLC | 09/20/2021 |
| 06/02/2021 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (right to buy) | 85k | $2.04 | $173.4k | | 06/02/2021 |
| 01/28/2021 | Astria Therapeutics, Inc. | ATXS | Grant | Stock Option (Right to Buy) | 15k | $2.43 | $36.4k | | 01/28/2021 |
| 01/18/2021 | Viridian Therapeutics, Inc.\DE | MGEN | Grant | Employee Stock Option (right to buy) | 800.1k | $23.03 | $18.4M | | 01/18/2021 |
| 10/27/2020 | Viridian Therapeutics, Inc.\DE | MGEN | Other (acquisition) | Common Stock | 50.1k | $0.00 | $0 | | 10/27/2020 |
| 10/27/2020 | Viridian Therapeutics, Inc.\DE | MGEN | Other (acquisition) | Employee Stock Option (Right to Buy) | 4.3M | $0.01 | $43.4k | | 10/27/2020 |
| 10/27/2020 | Viridian Therapeutics, Inc.\DE | MGEN | Other (acquisition) | Series A Non-Voting Convertible Preferred Stock | 9.4k | $0.00 | $0 | | 10/27/2020 |
| 02/28/2018 | TREVENA INC | TRVN | Grant | Employee Stock Option (Right to Buy) | 65k | $1.79 | $116.4k | | 02/28/2018 |
| 02/28/2018 | TREVENA INC | TRVN | Grant | Employee Stock Option (Right to Buy) | 75k | $1.79 | $134.2k | | 02/28/2018 |